Covid breakthrough as UK recruits for trial of wonderdrug tipped to slash hospitalisations | Science | News

According to the trial’s chief investigator, Professor Christ Butler, targetting Covid at an early stage is most beneficial.

He said: “It is early on in the illness, when people are still being cared for in the community, that treatments for COVID-19 could have their greatest benefit.

“This new trial will test whether exciting, new antiviral treatments that are more specific to COVID-19 help people in the community recover faster and reduce the need for treatment in hospital.”

Although past trials have already found a number of antiviral treatments to be safe and effective, the new trial will give researchers new insight into their effectiveness in communities with a high rate of vaccine coverage.

Government figures published on Wednesday indicate more than 119 million vaccines have already been administered across the UK.


See also  Mount Etna erupts in Sicily, spewing 100 metre lava fountains - Is it still erupting? | Science | News

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.